2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
April 24th, 2025
Version: 1
Johns Hopkins University
bioengineering
biorxiv

Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell response

Wei, C.Open in Google Scholar•Zhu, Y.Open in Google Scholar•Lu, X.Open in Google Scholar•Goodier, K. D.Open in Google Scholar•Yu, D.Open in Google Scholar•Liu, X.Open in Google Scholar•Choy, J.Open in Google Scholar•Tellez Calderon, A.Open in Google Scholar•Ma, J.Open in Google Scholar•Su, Y.Open in Google Scholaret al.

The mRNA lipid nanoparticles (LNPs) represent a new generation of vaccine carriers designed to elicit potent immune responses against infectious diseases and cancer. Despite the clinical success and rapid advancements in mRNA LNP technologies, the trafficking patterns of LNPs after intramuscular (i.m.) administration and the subsequent tissue-specific immunological effects have not been systematically characterized. Here, we report that trafficking of mRNA LNPs to different organs following i.m. injection is crucial for the induction of tissue-specific immunity beyond systemic immune response, particularly in tissue-resident CD8+ T cell generation, which is important for localized defense. By fine-tuning the composition of mRNA LNPs, trafficking patterns to systemic organs can be modulated, which can alter the resulting tissue-specific immune response. Formulations with a greater ability to enter the bloodstream can preferentially localize and transfect cells in specific organs like the liver, elicit stronger tissue-specific CD8+ T cell immune responses, and achieve enhanced efficacy in a liver tumor model. These findings highlight the potential to tailor mRNA LNP compositions to modulate trafficking following i.m. injection, thereby providing novel strategies for designing tissue-specific vaccines. Such strategies are particularly valuable for organ-specific diseases like cancer and infectious diseases, where tissue targeting and long-lasting immunity are essential for therapeutic success.

Similar Papers

biorxiv
Fri Apr 25 2025
HybriSeq: Probe-based Device-free Single-cell RNA Profiling
We have developed the HybriSeq method for single-cell RNA profiling, which utilizes in situ hybridization of multiple probes for targeted transcripts, followed by split-pool barcoding and sequencing analysis of the probes. We have shown that HybriSeq can achieve high sensitivity for RNA detection with multiple probes and profile entire transcripts without an end bias. The utility of HybriSeq is de...
Foyt, D.
•
Brown, D.
•
Zhou, S.
•
Moser, B.
...•
Huang, B.
biorxiv
Fri Apr 25 2025
A Dual-Fluorescence Assay for Gene Delivery Vehicle Screening in Macrophages with an Inflammation-Inducible Reporter Construct
Macrophages are a promising target for therapeutics in various applications such as regenerative medicine and immunotherapy for cancer. Due to their plastic nature, macrophages can switch from a non-activated state to activated with the smallest environmental change. For macrophages to be effective in their respective applications, screening for phenotypic changes is necessary to elucidate the cel...
Ivy, A.
•
Bess, S. N.
•
Agrawal, S.
•
Kochar, V.
...•
Nelson, C. E.
biorxiv
Fri Apr 25 2025
Intracortical Microstimulation Induces Rapid Microglia Process Convergence
Intracortical microstimulation (ICMS) has demonstrated the potential to restore vision and hearing by stimulating relevant cortical regions in both animals and humans, offering significant clinical promise for sensory restoration. While the neuronal response to ICMS has been extensively studied at the cellular level through electrophysiology and two-photon (2P) imaging, the response of non-neurona...
Williams, N. P.
•
Kelly, A. M.
•
Zheng, X. S.
•
Vazquez, A. L.
•
Cui, X. T.
biorxiv
Fri Apr 25 2025
Biomechanical Evaluation of Temporomandibular Joint Implants and Periprosthetic Bone under Unilateral and Bilateral Clenching
To ensure the long-term success of temporomandibular joint (TMJ) implants, it is imperative to understand their biomechanical performances. This study aims to compare the biomechanical performance of two stock implants (narrow and standard) under unilateral and bilateral clenching during both osseointegrated and non-osseointegrated conditions. Finite element models of a human mandible were develop...
Ghosh, R.
•
Chandra, G.
•
Verma, V.
•
Kaur, K.
...•
Mukherjee, K.
biorxiv
Thu Apr 24 2025
Mesoscopic whole-brain T2*-weighted and associated quantitative MRI in healthy humans at 10.5 T
Purpose: To demonstrate the feasibility and performance of mesoscopic whole brain T2*-weighted (T2*w) MRI at 10.5 T by combining a motion-robust multi-echo gradient-echo (GRE) method with high-density RF receive arrays. Methods: Multi-echo GRE data were collected in healthy adults at isotropic 0.5 mm resolution using a custom-built 16-channel transmit/80-channel receive (16Tx/80Rx) RF coil. Whole ...
Liu, J.
•
Van Gelderen, P.
•
de Zwart, J. A.
•
Duyn, J. H.
...•
Wu, X.
biorxiv
Thu Apr 24 2025
Norbornene homopolymerization limits cell spreading in thiol-ene photoclick hydrogels
Thiol-ene click chemistry is a powerful tool for designing hydrogels mimicking the mechanical and biochemical properties of 3D cellular microenvironments. The high selectivity of thiol-norbornene step-growth polymerization enables precise control of crosslinking mechanism, circumventing the alkene homopolymerization present in other systems that can prevent encapsulated cell spreading. Limited str...
Gentry, J. L.
•
Caliari, S. R.
biorxiv
Thu Apr 24 2025
Crowdsourced Protein Design: Lessons From the Adaptyv EGFR Binder Competition
In this report, we summarize and analyze the 2024 Adaptyv EGFR protein design competition. Participants used computational and ML methods of their choice to design proteins to bind the EGFR, a key drug target that plays a critical role in cell growth, differentiation, and cancer development. Over 1800 designs were submitted to the competition across two rounds. Of these, 601 proteins were selected...
Cotet, T.-S.
•
Krawczuk, I.
•
Stocco, F.
•
Ferruz, N.
...•
Adaptyv Competition Organizers,
biorxiv
Thu Apr 24 2025
In vivo generation of chimeric antigen receptor T cells using optimally retargeted and functionalized lentiviral vectors with reduced immune clearance
Despite striking efficacy against hematologic malignancies, the cost and complexity of CAR T manufacturing present significant barriers to broader patient access. Beyond manufacturing challenges, ex vivo expansion of T cells may be detrimental for their function and persistence. Thus, delivery of CARs to reprogram host cells in vivo would represent a significant advance toward \'off-the-shelf\' th...
Mears, K.
•
Ibrahim, K.
•
Allen, P. M.
•
Chinai, J. M.
...•
Manguso, R. T.
biorxiv
Thu Apr 24 2025
Meta-AlignNN: A meta-learning framework for stable brain-computer interface performance across subjects, time, and tasks
Practical application of brain-computer interfaces (BCIs) requires stable mapping between neuronal activity and behavior through various behavioral contexts and for different individuals. Due to neural activity instability, BCIs require frequent recalibration to maintain robust performance. Early approaches to addressing BCI stability issues mainly focused on tackling the challenge of neural activ...
Zou, Y.
•
Liu, K.
•
Zhang, C.
•
Ling, Y.
...•
Li, C. T.